Cargando…

GABAB receptor inhibits tumor progression and epithelial-mesenchymal transition via the regulation of Hippo/YAP1 pathway in colorectal cancer

Gamma-Aminobutyric Acid Type B Receptor (GABABR) plays essential roles in tumor progression. However, the function of GABABR in colorectal cancer (CRC) needs further clarification. As the main part of GABABR, GABABR1 expression was identified significantly lower in tumor tissues than those in non-tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huihui, Zhang, Hao, Sun, Zhirong, Chen, Wankun, Miao, Changhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193267/ https://www.ncbi.nlm.nih.gov/pubmed/34131398 http://dx.doi.org/10.7150/ijbs.58135

Ejemplares similares

WWC3 inhibits epithelial–mesenchymal transition of lung cancer by activating Hippo-YAP signaling
por: Han, Qiang, et al.
Publicado: (2018)

Effects of activating GABAB1 receptor on proliferation, migration, invasion and epithelial-mesenchymal transition of ovarian cancer cells
por: Gao, Jun, et al.
Publicado: (2020)

Notch3 inhibits epithelial–mesenchymal transition by activating Kibra-mediated Hippo/YAP signaling in breast cancer epithelial cells
por: Zhang, X, et al.
Publicado: (2016)

Intron 4 Containing Novel GABAB1 Isoforms Impair GABAB Receptor Function
por: Lee, Changhoon, et al.
Publicado: (2010)

SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells
por: Zhou, Hailang, et al.
Publicado: (2019)

Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling
por: Lee, Kang-Yun, et al.
Publicado: (2020)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

The Role of GABAB Receptors in Morphine Self-Administration
por: Ramshini, Effat, et al.
Publicado: (2013)

Regulating hippocampal hyperexcitability through GABAB Receptors
por: Lang, Min, et al.
Publicado: (2014)

Mouse hippocampal GABAB1 but not GABAB2 subunit-containing receptor complex levels are paralleling retrieval in the multiple-T-maze
por: Falsafi, Soheil K., et al.
Publicado: (2015)

Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages
por: Sun, Pengfei, et al.
Publicado: (2017)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis
por: Matarrese, Paola, et al.
Publicado: (2021)

Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats
por: Papon, Marie-Amélie, et al.
Publicado: (2020)

Eva‐1 homolog A promotes papillary thyroid cancer progression and epithelial‐mesenchymal transition via the Hippo signalling pathway
por: Lin, Bang‐Yi, et al.
Publicado: (2020)

SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
por: Zhang, Xiaotian, et al.
Publicado: (2022)

miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells
por: Yoshida, Masahiro, et al.
Publicado: (2019)

Src family kinases inhibit differentiation of intestinal epithelial cells through the Hippo effector YAP1
por: Fallah, Sepideh, et al.
Publicado: (2021)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation
por: Fallah, Sepideh, et al.
Publicado: (2020)

Pin1/YAP pathway mediates matrix stiffness‐induced epithelial–mesenchymal transition driving cervical cancer metastasis via a non‐Hippo mechanism
por: Yang, Long, et al.
Publicado: (2022)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells
por: Chai, Yanting, et al.
Publicado: (2018)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

The Hippo/YAP signaling pathway: the driver of cancer metastasis
por: Zhou, Tianxing, et al.
Publicado: (2023)

SCRIB Promotes Proliferation and Metastasis by Targeting Hippo/YAP Signalling in Colorectal Cancer
por: Shen, Hengyang, et al.
Publicado: (2021)

MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway
por: Chen, Wankun, et al.
Publicado: (2016)

Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway
por: Wang, Yifan, et al.
Publicado: (2016)

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
por: Wang, Yan, et al.
Publicado: (2021)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP
por: Dan, Weichao, et al.
Publicado: (2022)

Retracted: Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells
por: Chai, Yanting, et al.
Publicado: (2022)

NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression
por: Wang, Lijun, et al.
Publicado: (2021)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020)

Expression of YAP in endometrial carcinoma tissues and its effect on epithelial to mesenchymal transition
por: Cheng, Yun, et al.
Publicado: (2020)

Syndecan-2 modulates the YAP pathway in epithelial-to-mesenchymal transition-related migration, invasion, and drug resistance in colorectal cancer
por: Yang, Yang, et al.
Publicado: (2023)

Single-Molecule Fluorescence Imaging Reveals GABAB Receptor Aggregation State Changes
por: Luo, Fang, et al.
Publicado: (2022)

Post-transcriptional regulation of GABAB receptor and GIRK1 channels by Nogo receptor 1
por: Murthy, Rachana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_22siekrn18dtf47r7lm8719d4v